Soaring Eagle Acquisition Corp.

Status: Deal Closed
U=S+W/5 W=S@11.5
IPO Proceeds, $M $1,725.00M
IPO Date Feb 24, 2021
CEO Harry E. Sloan
Left Lead Goldman Sachs
IPO Cash in Trust 100.0%
SPAC Tenor 24+6
IPO Sector General

Not specified

IPO Geography Global
Target Company Ginkgo Bioworks
Deal Announced May 11, 2021
Deal Size, $M $15,164.00M
Deal Sector Healthcare
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Sep 14, 2021
Amendment Vote TBD
Closing Date Sep 17, 2021
Formerly SRNG DNA DNA/W

Sign up for Free Trial

No credit card required

Sign in for more on Soaring Eagle Acquisition Corp.:

  • Structure and cap table
  • 8 directors & officers
  • 31 filings and events
  • 1 underwriters
  • 12 deal advisors
  • 3 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Harry E. Sloan 70 Chief Executive Officer and Chairman
Eli Baker 45 President, Chief Financial Officer and Secretary
Scott M. Delman 61 Director
Joshua Kazam 43 Director
Dennis A. Miller 65 Director
Laurence E. Paul 56 Director
Isaac Lee 50 Director
Timothy Leiweke 63 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Goldman Sachs BR 150,000,000 units
150,000,000 units
Up-Front UW fee 1.50 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 31 filings.

Shareholders

Sign in to view shareholders 13F filing data.